[Form 4] KEWAUNEE SCIENTIFIC CORP /DE/ Insider Trading Activity

Rhea-AI Filing Summary

Thomas David Hull III, President, CEO and director of Kewaunee Scientific Corp (KEQU), reported two open-market sales of common stock on September 23-24, 2025. He sold 721 shares on 09/23/2025 at a weighted-average price shown as $44 and an additional 1,000 shares on 09/24/2025 at a weighted-average price shown as $43.62. After the September 23 trade his beneficial ownership was 42,573 shares and after the September 24 trade it was 41,573 shares. The form was signed by an attorney-in-fact on 09/24/2025. The filing includes a note that reported prices are weighted averages and that the filer will provide breakdowns on request.

Positive

• Complete disclosure of sale dates, share amounts, and weighted-average prices with an explicit offer to provide per-lot pricing upon request
• Filing covers both officer and director roles, clarifying the reporting person's relationship to the issuer

Negative

• Insider sold shares, reducing beneficial ownership from 42,573 to 41,573 shares
• No explanation provided for the sales (reason for sale not stated in the Form 4)

Insights

Corporate Governance Expert

TL;DR: Routine insider sales by the CEO/Director reducing his holdings; disclosure appears complete and compliant.

The report shows scheduled open-market disposals of common stock by the reporting person who serves as President, CEO and a director. Transaction prices are presented as weighted averages with an explicit offer to provide per-lot pricing on request, which aligns with Form 4 disclosure practices. The signature by an attorney-in-fact is documented. There is no additional context in the filing (no option exercises, no related-party transfers), so the disclosure is a straightforward record of sales rather than a corporate action or compensation change.

Securities Analyst

TL;DR: Insider sold 1,721 shares over two days; the transactions are material only to the extent of share count change disclosed.

The transactions total 1,721 shares sold across two dates with remaining beneficial ownership declining from 42,573 to 41,573 shares. Prices are given as weighted averages ($44 and $43.62). The filing does not state reasons for sale, nor does it indicate any derivative transactions. From an investor-impact perspective, these are routine disclosures showing liquidity events by an insider rather than firm-level operational developments.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

HULL THOMAS DAVID III

(Last) (First) (Middle)

2700 WEST FRONT STREET

(Street)

STATESVILLE NC 28677

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
KEWAUNEE SCIENTIFIC CORP /DE/ [ KEQU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, CEO

3. Date of Earliest Transaction (Month/Day/Year)
09/23/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/23/2025		S		721	D	$44(1)	42,573	D
Common Stock	09/24/2025		S		1,000	D	$43.62(1)	41,573	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reflects the weighted average purchase price of the transactions reported. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares purchased at each separate price.

Remarks:

	/s/ Donald T. Gardner III, Attorney-in-fact	09/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions were reported for KEQU on this Form 4?

The filing reports two open-market sales: 721 shares sold on 09/23/2025 at a weighted-average price of $44 and 1,000 shares sold on 09/24/2025 at a weighted-average price of $43.62.

Who is the reporting person on the KEQU Form 4?

The reporting person is Thomas David Hull III, identified as President, CEO and a director of Kewaunee Scientific Corp.

How many shares does the reporting person own after the reported transactions?

After the 09/24/2025 sale the reporting person beneficially owned 41,573 shares.

Are the prices given exact trade prices on the Form 4?

The Form 4 shows weighted-average prices ($44 and $43.62) and states the reporting person can provide the number of shares purchased at each separate price upon request.

Was the Form 4 signed by the reporting person?

The filing is signed by an attorney-in-fact, Donald T. Gardner III, with the signature dated 09/24/2025.